AI drug discovery company

Aqemia

Data as of Oct 17, 2026.

Company facts

Founded

2019

ReportedSource for founded (opens in new tab)
Headquarters

France (Paris)

ConfirmedSource for headquarters (opens in new tab)
Total funding

over $100M

ConfirmedSource for total funding (opens in new tab)

Latest funding round

Round: Funding round
Date: Dec 10, 2024
Amount: $38M
Lead investor: Cathay Innovation

ConfirmedSource for the latest round (opens in new tab)

Drug discovery partners

1 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

Sanofi Pharma

Research collaboration (expanded), Jul 17, 2026

$140M total potential (upfront not disclosed)

ConfirmedSource for Sanofi (opens in new tab)

Recent news

Jul 17, 2026

Aqemia and Sanofi expand their research collaboration

ConfirmedSource (opens in new tab)
Dec 9, 2025

To attend the J.P. Morgan Healthcare Conference 2026

ReportedSource (opens in new tab)
Nov 11, 2025

To present at the Jefferies Global Healthcare Conference 2025

ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.